Spots Global Cancer Trial Database for Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
Official Title: Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 as Second- or Later- Line Treatment in Patients With Advanced Non-Small Cell Lung Cancer
Study ID: NCT00094094
Interventions
Study Description
Brief Summary: This is a Phase 2 study being conducted at multiple centers in the United States and Germany. Patients having non-small cell lung cancer that has spread to other parts of the body (i.e., metastatic) or is locally advanced (i.e., Stage IIIB with malignant pleural effusion) are eligible to participate. Patients must have disease that has been treated with at least 1 prior treatment for metastatic disease (prior adjuvant treatment for localized disease does not count as prior treatment for metastatic disease). The purpose of the study is to test whether the angiogenesis inhibitor AG-013736 is an effective treatment for advanced non-small cell lung cancer as shown by the number of patients in the study who experience significant and durable tumor shrinkage
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Irvine, California, United States
Pfizer Investigational Site, Orange, California, United States
Pfizer Investigational Site, Chicago, Illinois, United States
Pfizer Investigational Site, Park Ridge, Illinois, United States
Pfizer Investigational Site, Coon Rapids, Minnesota, United States
Pfizer Investigational Site, Fridley, Minnesota, United States
Pfizer Investigational Site, Robbinsdale, Minnesota, United States
Pfizer Investigational Site, Charlotte, North Carolina, United States
Pfizer Investigational Site, Nashville, Tennessee, United States
Pfizer Investigational Site, Madison, Wisconsin, United States
Pfizer Investigational Site, Gauting, , Germany
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
